Patents by Inventor Peng Cui

Peng Cui has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260030875
    Abstract: A method for training a lane line detection model includes (i) obtaining a dataset comprising a plurality of road image samples, wherein the road image samples have lane line labels, (ii) extracting lane line feature vectors of the road image samples by way of an image segmentation model and the lane line labels of the road image samples, (iii) determining the lane line detection difficulty of the road image samples based on the lane line feature vectors of the road image samples, and (iv) training the lane line detection model using the road image samples in the dataset and a loss function based on the lane line detection difficulty of the road image samples.
    Type: Application
    Filed: July 16, 2025
    Publication date: January 29, 2026
    Inventors: Wanfang Chen, Shu Liu, Kaixuan Zhang, Peng Cui, Jianing Huang
  • Patent number: 12421579
    Abstract: Six-membered high-entropy foam for hydrogen production by water splitting and preparation method are provided. The foam consists of Ni, Fe, Cu, Co, Mo, and Pt, comprising 10 at %-25 at % of Ni, 10 at %-25 at % of Fe, 10 at %-25 at % of Cu, 10 at %-25 at % of Co, 10 at %-25 at % of Mo, and 10 at %-25 at % of Pt. Catalyst loading of the foam can reach a range of 0.8 mg/cm2-3.2 mg/cm2, which is much higher than the effective catalyst loading of most nano-catalysts. When used as catalyst for hydrogen production by water splitting, the hydrogen evolution overpotential of the surface of the six-membered high-entropy foam is within a range of 36 mV-60 mV, and the foam operates stably at industrial-level current density (500 mA/cm2). The preparation method does not require harsh environment such as high temperature or high vacuum, making the method simple and easy to implement, with low-cost raw materials.
    Type: Grant
    Filed: November 7, 2024
    Date of Patent: September 23, 2025
    Assignee: SOUTHEAST UNIVERSITY
    Inventors: Xuhai Zhang, Tongheng Wang, Yuqiao Zeng, Peng Cui, Chongyang Ba, Feng Fang, Qiyue Shao, Haoran Zheng, Pengcheng Zhao, Jianqing Jiang
  • Patent number: 12371477
    Abstract: Provided is an isolated binding protein including an antigen binding domain binding to an NS1 protein, and comprising specific heavy chain CDR and light chain CDR. The binding protein can specifically identify and bind to NS1, and has relatively high sensitivity and specificity, so as to detect dengue virus. Moreover, the binding protein does not need to be produced by injecting hybridoma cells into mouse peritoneal cavity, while simplifying production, thus stabilizing antibody functionality.
    Type: Grant
    Filed: August 26, 2019
    Date of Patent: July 29, 2025
    Assignee: Fapon Biotech Inc.
    Inventors: Peng Cui, Zhiqiang He, Yuan Meng, Dongmei Zhong
  • Publication number: 20250231141
    Abstract: Embodiments of the present disclosure are directed to charge variants of a protein such as vascular endothelial growth factor VEGF-Trap, and methods, systems, devices and kits corresponding to methods for analyzing the same.
    Type: Application
    Filed: January 16, 2025
    Publication date: July 17, 2025
    Inventors: Anu RAMBHADRAN, Peng CUI, Paul BIGWARFE, Michele LASTRO, Clare RYAN, Junyu MA, Kun LU
  • Publication number: 20250145694
    Abstract: Provided are an isolated binding protein including an antigen binding domain of cardiac troponin I (cTnI), as well as a preparation and uses of the binding protein. The antigen binding domain includes at least one complementary determining region selected from the amino acid sequences defined herein; or the antigen-binding domain has at least 80% sequence identity with the complementary determining regions of said amino acid sequences and has an affinity for cardiac troponin I of KD?3.33×10?8 mo/L. The binding protein may be used in the field of cTnI protein detection.
    Type: Application
    Filed: September 27, 2019
    Publication date: May 8, 2025
    Inventors: Peng CUI, Zhiqiang HE, Yuan MENG, Ricai HAN, Dongmei ZHONG, Lingyun FAN
  • Patent number: 12291564
    Abstract: Provided is an isolated binding protein including an antigen-binding domain that binds to NS1 protein. The isolated binding protein includes specific heavy chain CDRs and light chain CDRs. The binding protein can specifically recognize and bind to NS1, and has relatively high sensitivity and specificity, thereby achieving the detection of dengue virus. Moreover, the binding protein is not required to be produced by inducing hybridoma cells in mouse abdominal cavity, and thus it is simple in production and has more stable antibody function.
    Type: Grant
    Filed: August 26, 2019
    Date of Patent: May 6, 2025
    Assignee: FAPON BIOTECH INC.
    Inventors: Peng Cui, Zhiqiang He, Yuan Meng, Dongmei Zhong
  • Patent number: 12281157
    Abstract: Provided is an isolated binding protein including an antigen binding domain binding to an NS1 protein, and including specific heavy chain CDR and light chain CDR. The binding protein can specifically identify and bind to NS1, and has relatively high sensitivity and specificity, so as to detect dengue vims. Moreover, the binding protein does not need to be produced by injecting hybridoma cells into mouse peritoneal cavity, while simplifying production, thus stabilizing antibody functionality.
    Type: Grant
    Filed: August 26, 2019
    Date of Patent: April 22, 2025
    Assignee: Fapon Biotech Inc.
    Inventors: Peng Cui, Zhiqiang He, Yuan Meng, Dongmei Zhong
  • Publication number: 20250122633
    Abstract: Six-membered high-entropy foam for hydrogen production by water splitting and preparation method are provided. The foam consists of Ni, Fe, Cu, Co, Mo, and Pt, comprising 10 at %-25 at % of Ni, 10 at %-25 at % of Fe, 10 at %-25 at % of Cu, 10 at %-25 at % of Co, 10 at %-25 at % of Mo, and 10 at %-25 at % of Pt. Catalyst loading of the foam can reach a range of 0.8 mg/cm2-3.2 mg/cm2, which is much higher than the effective catalyst loading of most nano-catalysts. When used as catalyst for hydrogen production by water splitting, the hydrogen evolution overpotential of the surface of the six-membered high-entropy foam is within a range of 36 mV-60 mV, and the foam operates stably at industrial-level current density (500 mA/cm2). The preparation method does not require harsh environment such as high temperature or high vacuum, making the method simple and easy to implement, with low-cost raw materials.
    Type: Application
    Filed: November 7, 2024
    Publication date: April 17, 2025
    Applicant: SOUTHEAST UNIVERSITY
    Inventors: Xuhai ZHANG, Tongheng WANG, Yuqiao ZENG, Peng CUI, Chongyang BA, Feng FANG, Qiyue SHAO, Haoran ZHENG, Pengcheng ZHAO, Jianqing JIANG
  • Patent number: 12173056
    Abstract: Disclosed is an isolated binding protein including a cardiac troponin I (cTnI) antigen binding domain, and preparation and a use and the like of the binding protein. The antigen binding domain includes at least one complementarity determining region selected from an amino acid sequence defined in this article, or has at least 80% sequence identity with the complementarity determining region of the amino acid sequence and has KD?9.96×10?8 mol/L affinity with cTnI. The binding protein may be used in the detection field of the cTnI protein.
    Type: Grant
    Filed: September 27, 2019
    Date of Patent: December 24, 2024
    Assignee: FAPON BIOTECH INC.
    Inventors: Peng Cui, Zhiqiang He, Yuan Meng, Dongmei Zhong
  • Patent number: 12158469
    Abstract: The present disclosure relates to the field of medical diagnosis, and specifically, relates to a synthetic peptide for detecting HIV-1. The synthetic peptide is obtained by mutating the amino acid sequence set forth as SEQ ID NO: 1. The synthetic peptide can better detect anti-HIV-1 antibodies, and can better avoid potential “false negative” and “false positive” results.
    Type: Grant
    Filed: August 6, 2019
    Date of Patent: December 3, 2024
    Assignee: Fapon Biotech Inc.
    Inventors: Peng Cui, Zhiqiang He, Yuan Meng
  • Patent number: 12024842
    Abstract: The method for preventing and controlling glacial lake outbreak flood and related debris flows by the present invention is mainly controlling the scale of the floods by separating water and rocks and dispersing its energy step by step. The cascading amplification effects of floods can be reduced by controlling the initiation of source material with energy dissipation by using ground sills, groups of piles, and placed large stones and prefabricated artificial structures. The diversion dam built in the downstream area discharge floods in different layers, which can quickly guide water to the main river. The preconstructed engineering system can be used in a timely manner to prevent and control floods and debris flows induced by a sudden outburst of glacial lakes in areas with important facilities and inhabitants enduring the risk of natural hazards. Prevention and control systems can separate floods and debris flows and dissipate their energy.
    Type: Grant
    Filed: August 28, 2020
    Date of Patent: July 2, 2024
    Assignee: INSTITUTE OF MOUNTAIN HAZARDS AND ENVIRONMENT CHINESE ACADEMY OF SCIENCES
    Inventors: Jiangang Chen, Xiaoqing Chen, Peng Cui, Yong You, Huayong Chen, Shuai Li, Jinbo Tang, Wanyu Zhao, Lu Zneg, Xian Wang
  • Publication number: 20240158475
    Abstract: Provided is an isolated binding protein including an antigen binding domain binding to an NS1 protein, and comprising specific heavy chain CDR and light chain CDR. The binding protein can specifically identify and bind to NS1, and has relatively high sensitivity and specificity, so as to detect dengue virus. Moreover, the binding protein does not need to be produced by injecting hybridoma cells into mouse peritoneal cavity, while simplifying production, thus stabilizing antibody functionality.
    Type: Application
    Filed: August 26, 2019
    Publication date: May 16, 2024
    Inventors: Peng CUI, Zhiqiang HE, Yuan MENG, Dongmei ZHONG
  • Publication number: 20230391853
    Abstract: An antibody against a novel coronavirus, and a reagent and a kit for detecting the novel coronavirus, which relate to the technical field of antibodies. The antibody against the novel coronavirus includes a heavy chain complementarity determinant region and a light chain complementarity determinant region. The antibody has good affinity for N protein of the novel coronavirus, and has good sensitivity and specificity for detecting the novel coronavirus. Antibody options are provided for detection of the novel coronavirus.
    Type: Application
    Filed: September 10, 2021
    Publication date: December 7, 2023
    Inventors: Peng CUI, Zhiqiang HE, Yuan MENG, Dongmei ZHONG, Wenjuan LOU, Lingyun FAN
  • Publication number: 20230331784
    Abstract: The present disclosure relates to an HCV recombinant antigen and use of the same. Provided is an HCV recombinant antigen, which includes at least two NS3 antigens, at least one NS4 antigen, and at least one core antigen. Further provided are a nucleic acid encoding the HCV recombinant antigen, an expression vector containing the nucleic acid, a host cell containing the expression vector, a conjugate containing the HCV recombinant antigen, and a kit containing the HCV recombinant antigen, and the like.
    Type: Application
    Filed: April 16, 2021
    Publication date: October 19, 2023
    Inventors: Peng CUI, Zhiqiang HE, Yuan MENG, Zhongjie WEI, Jing CEN
  • Patent number: D1088641
    Type: Grant
    Filed: April 2, 2025
    Date of Patent: August 19, 2025
    Inventor: Peng Cui
  • Patent number: D1100544
    Type: Grant
    Filed: April 9, 2024
    Date of Patent: November 4, 2025
    Inventor: Peng Cui
  • Patent number: D1100545
    Type: Grant
    Filed: April 9, 2024
    Date of Patent: November 4, 2025
    Inventor: Peng Cui
  • Patent number: D1103482
    Type: Grant
    Filed: January 11, 2023
    Date of Patent: November 25, 2025
    Assignee: Annie International .Inc.
    Inventor: Peng Cui
  • Patent number: D1107302
    Type: Grant
    Filed: April 10, 2023
    Date of Patent: December 23, 2025
    Assignee: Annie International, Inc.
    Inventor: Peng Cui
  • Patent number: D1109554
    Type: Grant
    Filed: April 9, 2024
    Date of Patent: January 20, 2026
    Inventor: Peng Cui